The commonest male ejaculation disorder is Premature Ejaculation (PE). Inhibited or Delayed Ejaculation can be a more challenging condition to assess and treat. This discussion will focus on the diagnosis, investigations and management of ejaculation problems including an overview of the first medication specifically approved for the treatment of PE, dapoxetine, released under the trade name of Priligy™.
Testosterone, the male hormone: controversies of treatment. The male hormone testosterone maintains good health and sexual function and a sense of wellbeing. This workshop will discuss the recommended guidelines for the diagnosis, appropriate investigation and detection of other associated health conditions as well as the various treatment options available to clinicians.